Recombinant CD27 (Varlilumab Biosimilar) antibody
Research Grade
Reactivity: Human
Host: Human
Monoclonal
unconjugated
Recombinant Antibody
-
- Target See all CD27 (Varlilumab Biosimilar) products
- CD27 (Varlilumab Biosimilar)
- Antibody Type
- Recombinant Antibody
- Reactivity
- Human
-
Host
-
Human
- Expression System
- Mammalian cells
-
Clonality
- Monoclonal
-
Conjugate
- This CD27 (Varlilumab Biosimilar) antibody is un-conjugated
- Application
- Please inquire
- Purpose
- Research Grade Varlilumab Biosimilar Antibody
- Specificity
- CD27L receptor, TNFRSF7, T14, CD27 antigen, Tumor necrosis factor receptor superfamily member 7, CD27, T-cell activation antigen CD27
- Purification
- Protein A or G purified from cell culture supernatant.
- Purity
- >95 % by SDS-PAGE.
- Grade
- Research Grade
- Isotype
- IgG1 kappa
-
anti-CD27 (Varlilumab Biosimilar) antibody
Research Grade Reactivity: Human ELISA, FACS Host: Human Monoclonal unconjugated Recombinant Antibody
-
- Restrictions
- For Research Use only
-
- Format
- Liquid
- Concentration
- 2 mg/mL
- Buffer
- 0.01M PBS, pH 7.4.
- Storage
- 4 °C,-20 °C,-80 °C
- Storage Comment
- Use a manual defrost freezer and avoid repeated freeze-thaw cycles.Store at +4°C short term (1-2 weeks).Store at -20 °C 12 months. Store at -80°C long term.
- Expiry Date
- 12 months
-
- Target
- CD27 (Varlilumab Biosimilar)
- Alternative Name
- Varlilumab Biosimilar (CD27 (Varlilumab Biosimilar) Products)
- Target Type
- Biosimilar
- Background
- CD27L receptor, TNFRSF7, T14, CD27 antigen, Tumor necrosis factor receptor superfamily member 7, CD27, T-cell activation antigen CD27
- UniProt
- P26842
- CAS-No
- 1393344-72-3
-
You are here:
